Cargando…
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
PURPOSE OF REVIEW: Currently, cardiotoxicity is monitored through echocardiography or multigated acquisition scanning and is defined as 10% or higher LVEF reduction. The latter stage may represent irreversible myocardium injury and limits modification of therapeutic paradigms at earliest stages. To...
Autores principales: | Sivapackiam, Jothilingam, Sharma, Monica, Schindler, Thomas H., Sharma, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305065/ https://www.ncbi.nlm.nih.gov/pubmed/32562004 http://dx.doi.org/10.1007/s11886-020-01315-z |
Ejemplares similares
-
PET Imaging of Post-infarct Myocardial Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2021) -
Regulatory Agencies and PET/CT Imaging in the Clinic
por: Herscovitch, Peter
Publicado: (2022) -
PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis
por: Bauwens, Matthias, et al.
Publicado: (2015) -
PET Tracers for Imaging Cardiac Function in Cardio-oncology
por: Kelly, James M., et al.
Publicado: (2022) -
PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis
por: Celeng, Csilla, et al.
Publicado: (2018)